Skin Cancer Near the Eye: Warning Signs and When to Seek Evaluation

A transient lump near the eye that appears and disappears is unlikely to be skin cancer. Malignant eyelid and periorbital lesions typically exhibit persistent, progressive changes rather than coming and going. However, any new or changing lesion in this cosmetically and functionally sensitive area warrants professional evaluation.

Features Suggestive of Malignancy

Skin cancers (basal cell carcinoma, squamous cell carcinoma, sebaceous carcinoma, melanoma) in the periorbital region typically:

• Persist and grow over weeks to months (do not resolve spontaneously).
• Change in color, texture, or borders (pearly/translucent nodule, ulceration, telangiectasias, pigmentation irregularity).
• Ulcerate or bleed spontaneously or with minimal trauma.
• Destroy normal anatomy (loss of lashes, eyelid margin distortion, madarosis).
• Are usually painless (pain suggests inflammation/infection rather than malignancy, though not definitive).

Common Periorbital Skin Cancers

• Basal Cell Carcinoma (BCC): 90% of eyelid malignancies; pearly nodule with telangiectasias, central ulceration ("rodent ulcer"); locally invasive, rarely metastasizes.
• Squamous Cell Carcinoma (SCC): 5-10%; scaly, crusted, ulcerated plaque; higher metastatic potential.
• Sebaceous Carcinoma: Rare, aggressive; mimics chalazion or blepharitis; arises from meibomian glands; pagetoid spread.
• Melanoma: <1%; pigmented (or amelanotic) lesion with ABCDE features; high metastatic risk.

Benign Mimics (Often Transient)

• Chalazion (meibomian gland cyst) — fluctuates, may drain spontaneously.
• Hordeolum (stye) — acute, painful, resolves with warm compresses.
• Epidermal inclusion cyst — mobile, skin-colored nodule.
• Dermatofibroma, pyogenic granuloma, xanthelasma.
• Allergic/contact dermatitis — itchy, erythematous, resolves with allergen removal.

Action Steps

1. Document: Photograph the lesion with date stamp; track changes.
2. Don't self-diagnose: Even clinicians need biopsy for definitive diagnosis.
3. See a dermatologist or oculoplastic surgeon for any new/changing periorbital lesion persisting >2-4 weeks.
4. Biopsy (shave, punch, or excisional) provides histologic confirmation.
5. Early treatment (excision, Mohs surgery, radiation, topical therapy) yields excellent cure rates and optimal cosmetic/functional outcomes.

Early detection vastly improves outcomes for periorbital skin cancer. When in doubt, have it checked—your eyes and vision deserve expert care.